Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation

Inclusion Criteria: * Male or female patient younger than 18 but not younger than 2 years of age * Skeletal age of boys \< or = 17, girls \< or = 15 years * Patient has end stage kidney disease * Female patient of childbearing potential must have a negative serum pregnancy test prior to enrolment and must agree to practice effective birth control during the study and 6 weeks thereafter. * The patient, or in case the patient is a minor, the patient's parent(s) or their legal representative, has been fully informed and has given written informed consent Exclusion Criteria: * Patient has a most recently measured panel reactive antibody (PRA) grade of \> or = 50% * Patient is allergic to or intolerant of study medication * Patient and/or donor is known to be HIV positive. * Patient has significant liver disease * Patient with malignancy or history of malignancy * Patient has previously received or is receiving an organ transplant other than kidney. * Patient has been previously enrolled in this study. * Patient with the relapsing and non-diarrhoeal form of haemolytic uraemic syndrome.